TickerFacts.

Vycor Medical Inc (VYCO): Cash & Equivalents

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2019-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$87.0K
As of 2025-12-31
$158.9K
As of 2026-06-30
+32.9%
3-year compound annual growth
+13.6%
5-year compound annual growth
$1.89M2010-12-31: $127.1K2011-12-31: $950.8K2012-12-31: $59.8K2013-12-31: $31.3K2014-12-31: $1.89M2015-12-31: $347.5K2016-12-31: $56.9K2017-12-31: $206.2K2018-12-31: $86.5K2019-12-31: $60.7K2020-12-31: $46.0K2021-12-31: $90.9K2022-12-31: $37.0K2023-12-31: $57.3K2024-12-31: $105.6K2025-12-31: $87.0K$87.0K
2010-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$87.0K-17.7%2026-03-31, Balance as of period end
2024-12-31$105.6K+84.4%2026-03-31, Balance as of period end
2023-12-31$57.3K+54.7%2025-04-15, Balance as of period end
2022-12-31$37.0K-59.3%2024-04-16, Balance as of period end
2021-12-31$90.9K+97.7%2023-04-14, Balance as of period end
2020-12-31$46.0K-24.2%2022-04-13, Balance as of period end
2019-12-31$60.7Kn/c2021-03-31, Balance as of period end
2018-12-31$86.5K-58.1%2020-03-27, Balance as of period end
2017-12-31$206.2K+262.7%2019-03-29, Balance as of period end
2016-12-31$56.9K-83.6%2018-03-30, Balance as of period end
2015-12-31$347.5K-81.6%2017-03-31, Balance as of period end
2014-12-31$1.89Mn/m2015-03-31, Balance as of period end
2013-12-31$31.3K-47.7%2015-03-31, Balance as of period end
2012-12-31$59.8K-93.7%2014-04-07, Balance as of period end
2011-12-31$950.8K+648.2%2013-04-01, Balance as of period end
2010-12-31$127.1Kn/a2012-03-30, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Vycor Medical Inc (VYCO)2025-12-31$87.0K-17.7%
EBR Systems, Inc. (NONE.)2025-12-31$5.79M-16.2%
Femasys Inc (FEMY)2025-12-31$9.27M+168.5%
QHSLab, Inc. (USAQ)2025-12-31$636.2K+304.8%
OSR Health, Inc. (OSRH)2025-12-31$1.70M+397.8%
RenovoRx, Inc. (RNXT)2025-12-31$7.02M-1.8%
Nuo Therapeutics, Inc. (AURX)2025-12-31$548.9K+93.5%
IceCure Medical Ltd. (ICCM)2025-12-31$8.90M+17.6%
Sintx Technologies, Inc. (SINT)2025-12-31$4.14M+15.1%

Compare VYCO, NONE., FEMY, USAQ side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗